Biotech · Private company
Genocea Biosciences, Inc.
Track this companyFree. Adds Genocea Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- GEN-003Phase 2 · Genital HerpesClinicalTrials.gov · fetched Nov 12, 2026
- GEN-009 Adjuvanted VaccinePhase 2 · Cutaneous MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Matrix-M2Phase 2 · Genital HerpesClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Cutaneous MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Cutaneous MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- GEN-011Phase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IL-2Phase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell TherapyPHASE1 · TERMINATED · started Nov 11, 2020ClinicalTrials.gov NCT04596033 · fetched Nov 12, 2026
- Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted VaccinePHASE1_PHASE2 · COMPLETED · started Aug 29, 2018ClinicalTrials.gov NCT03633110 · fetched Nov 12, 2026
- Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes InfectionPHASE2 · TERMINATED · started May 24, 2017ClinicalTrials.gov NCT03146403 · fetched Nov 12, 2026